As the global economy mends, the 2021 growth of CRISPR Gene Detection and Diagnostic will have significant change from previous year. According to our (Publisher) latest study, the global CRISPR Gene Detection and Diagnostic market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global CRISPR Gene Detection and Diagnostic market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States CRISPR Gene Detection and Diagnostic market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global CRISPR Gene Detection and Diagnostic market, reaching US$ million by the year 2028. As for the Europe CRISPR Gene Detection and Diagnostic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main CRISPR Gene Detection and Diagnostic players cover Roche Molecular Diagnostics, Sherlock Biosciences, Thermo Fisher Scientific Inc., and Aelian Biotechnology, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR Gene Detection and Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Cutting Function Detection Method
Positioning Function Detection Method
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche Molecular Diagnostics
Sherlock Biosciences
Thermo Fisher Scientific Inc.
Aelian Biotechnology
Vivlion
Beckman Coulter Diagnostics
Binx Health
bioM?rieux Diagnostics
Caspr Biotech
Agilent
Axxam
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Bio-Rad Laboratories, Inc
10x Genomics, Inc.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CRISPR Gene Detection and Diagnostic Market Size 2017-2028
2.1.2 CRISPR Gene Detection and Diagnostic Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CRISPR Gene Detection and Diagnostic Segment by Type
2.2.1 Cutting Function Detection Method
2.2.2 Positioning Function Detection Method
2.3 CRISPR Gene Detection and Diagnostic Market Size by Type
2.3.1 CRISPR Gene Detection and Diagnostic Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CRISPR Gene Detection and Diagnostic Market Size Market Share by Type (2017-2022)
2.4 CRISPR Gene Detection and Diagnostic Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 CRISPR Gene Detection and Diagnostic Market Size by Application
2.5.1 CRISPR Gene Detection and Diagnostic Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CRISPR Gene Detection and Diagnostic Market Size Market Share by Application (2017-2022)
3 CRISPR Gene Detection and Diagnostic Market Size by Player
3.1 CRISPR Gene Detection and Diagnostic Market Size Market Share by Players
3.1.1 Global CRISPR Gene Detection and Diagnostic Revenue by Players (2020-2022)
3.1.2 Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Players (2020-2022)
3.2 Global CRISPR Gene Detection and Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR Gene Detection and Diagnostic by Regions
4.1 CRISPR Gene Detection and Diagnostic Market Size by Regions (2017-2022)
4.2 Americas CRISPR Gene Detection and Diagnostic Market Size Growth (2017-2022)
4.3 APAC CRISPR Gene Detection and Diagnostic Market Size Growth (2017-2022)
4.4 Europe CRISPR Gene Detection and Diagnostic Market Size Growth (2017-2022)
4.5 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size Growth (2017-2022)
5 Americas
5.1 Americas CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022)
5.2 Americas CRISPR Gene Detection and Diagnostic Market Size by Type (2017-2022)
5.3 Americas CRISPR Gene Detection and Diagnostic Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR Gene Detection and Diagnostic Market Size by Region (2017-2022)
6.2 APAC CRISPR Gene Detection and Diagnostic Market Size by Type (2017-2022)
6.3 APAC CRISPR Gene Detection and Diagnostic Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CRISPR Gene Detection and Diagnostic by Country (2017-2022)
7.2 Europe CRISPR Gene Detection and Diagnostic Market Size by Type (2017-2022)
7.3 Europe CRISPR Gene Detection and Diagnostic Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CRISPR Gene Detection and Diagnostic by Region (2017-2022)
8.2 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Type (2017-2022)
8.3 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CRISPR Gene Detection and Diagnostic Market Forecast
10.1 Global CRISPR Gene Detection and Diagnostic Forecast by Regions (2023-2028)
10.1.1 Global CRISPR Gene Detection and Diagnostic Forecast by Regions (2023-2028)
10.1.2 Americas CRISPR Gene Detection and Diagnostic Forecast
10.1.3 APAC CRISPR Gene Detection and Diagnostic Forecast
10.1.4 Europe CRISPR Gene Detection and Diagnostic Forecast
10.1.5 Middle East & Africa CRISPR Gene Detection and Diagnostic Forecast
10.2 Americas CRISPR Gene Detection and Diagnostic Forecast by Country (2023-2028)
10.2.1 United States CRISPR Gene Detection and Diagnostic Market Forecast
10.2.2 Canada CRISPR Gene Detection and Diagnostic Market Forecast
10.2.3 Mexico CRISPR Gene Detection and Diagnostic Market Forecast
10.2.4 Brazil CRISPR Gene Detection and Diagnostic Market Forecast
10.3 APAC CRISPR Gene Detection and Diagnostic Forecast by Region (2023-2028)
10.3.1 China CRISPR Gene Detection and Diagnostic Market Forecast
10.3.2 Japan CRISPR Gene Detection and Diagnostic Market Forecast
10.3.3 Korea CRISPR Gene Detection and Diagnostic Market Forecast
10.3.4 Southeast Asia CRISPR Gene Detection and Diagnostic Market Forecast
10.3.5 India CRISPR Gene Detection and Diagnostic Market Forecast
10.3.6 Australia CRISPR Gene Detection and Diagnostic Market Forecast
10.4 Europe CRISPR Gene Detection and Diagnostic Forecast by Country (2023-2028)
10.4.1 Germany CRISPR Gene Detection and Diagnostic Market Forecast
10.4.2 France CRISPR Gene Detection and Diagnostic Market Forecast
10.4.3 UK CRISPR Gene Detection and Diagnostic Market Forecast
10.4.4 Italy CRISPR Gene Detection and Diagnostic Market Forecast
10.4.5 Russia CRISPR Gene Detection and Diagnostic Market Forecast
10.5 Middle East & Africa CRISPR Gene Detection and Diagnostic Forecast by Region (2023-2028)
10.5.1 Egypt CRISPR Gene Detection and Diagnostic Market Forecast
10.5.2 South Africa CRISPR Gene Detection and Diagnostic Market Forecast
10.5.3 Israel CRISPR Gene Detection and Diagnostic Market Forecast
10.5.4 Turkey CRISPR Gene Detection and Diagnostic Market Forecast
10.5.5 GCC Countries CRISPR Gene Detection and Diagnostic Market Forecast
10.6 Global CRISPR Gene Detection and Diagnostic Forecast by Type (2023-2028)
10.7 Global CRISPR Gene Detection and Diagnostic Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche Molecular Diagnostics
11.1.1 Roche Molecular Diagnostics Company Information
11.1.2 Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Product Offered
11.1.3 Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Molecular Diagnostics Main Business Overview
11.1.5 Roche Molecular Diagnostics Latest Developments
11.2 Sherlock Biosciences
11.2.1 Sherlock Biosciences Company Information
11.2.2 Sherlock Biosciences CRISPR Gene Detection and Diagnostic Product Offered
11.2.3 Sherlock Biosciences CRISPR Gene Detection and Diagnostic Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sherlock Biosciences Main Business Overview
11.2.5 Sherlock Biosciences Latest Developments
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Information
11.3.2 Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Product Offered
11.3.3 Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Thermo Fisher Scientific Inc. Main Business Overview
11.3.5 Thermo Fisher Scientific Inc. Latest Developments
11.4 Aelian Biotechnology
11.4.1 Aelian Biotechnology Company Information
11.4.2 Aelian Biotechnology CRISPR Gene Detection and Diagnostic Product Offered
11.4.3 Aelian Biotechnology CRISPR Gene Detection and Diagnostic Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Aelian Biotechnology Main Business Overview
11.4.5 Aelian Biotechnology Latest Developments
11.5 Vivlion
11.5.1 Vivlion Company Information
11.5.2 Vivlion CRISPR Gene Detection and Diagnostic Product Offered
11.5.3 Vivlion CRISPR Gene Detection and Diagnostic Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Vivlion Main Business Overview
11.5.5 Vivlion Latest Developments
11.6 Beckman Coulter Diagnostics
11.6.1 Beckman Coulter Diagnostics Company Information
11.6.2 Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Product Offered
11.6.3 Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Beckman Coulter Diagnostics Main Business Overview
11.6.5 Beckman Coulter Diagnostics Latest Developments
11.7 Binx Health
11.7.1 Binx Health Company Information
11.7.2 Binx Health CRISPR Gene Detection and Diagnostic Product Offered
11.7.3 Binx Health CRISPR Gene Detection and Diagnostic Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Binx Health Main Business Overview
11.7.5 Binx Health Latest Developments
11.8 bioM